Abstract
A group of 4H-1,2,4-triazole-derived thioureas was efficiently prepared and evaluated for antibacterial, antifungal and antiviral activities.The chemical identity of all derivatives was established on the basis of spectral methods. The molecular structures of 10 and 21 were determined by an X-ray crystallography. Compounds with phenyl (1), 3,4-dichlorophenyl (2) and p-methoxyphenyl (3) substituents were the most promising against fungi species. The derivative 12 has proved to be significantly active against CVB-5. The CNS-activity of five new 4H-1,2,4-triazolo-thiourea derivatives 2, 10, 12, 18 and 21 was investigated. The results proved that activity of all tested thiourea compounds may be connected with the serotonergic system. Derivatives 2, 10, 12, 18 acted as inhibitors of the head twitch responses (HTR).The biological activity of 21 was also linked with the endogenous opioid system. The derivative 18 diminished the spontaneous mobility and 10 reduced the amphetamineinduced activity of laboratory animals.
Keywords: Antifungal activity, antiviral activity, CNS activity, thiourea, 1, 2, 4-triazole, X-ray crystallography.
Letters in Drug Design & Discovery
Title:Synthesis, Antimicrobial and Pharmacological Evaluation of Thioureaderivatives of 4H-1,2,4-triazole
Volume: 12 Issue: 4
Author(s): Anna Bielenica, Ewa Kedzierska, Sylwia Fidecka, Hanna Maluszynska, Barbara Miroslaw, Anna E. Koziol, Joanna Stefanska, Silvia Madeddu, Gabriele Giliberti, Giuseppina Sanna and Marta Struga
Affiliation:
Keywords: Antifungal activity, antiviral activity, CNS activity, thiourea, 1, 2, 4-triazole, X-ray crystallography.
Abstract: A group of 4H-1,2,4-triazole-derived thioureas was efficiently prepared and evaluated for antibacterial, antifungal and antiviral activities.The chemical identity of all derivatives was established on the basis of spectral methods. The molecular structures of 10 and 21 were determined by an X-ray crystallography. Compounds with phenyl (1), 3,4-dichlorophenyl (2) and p-methoxyphenyl (3) substituents were the most promising against fungi species. The derivative 12 has proved to be significantly active against CVB-5. The CNS-activity of five new 4H-1,2,4-triazolo-thiourea derivatives 2, 10, 12, 18 and 21 was investigated. The results proved that activity of all tested thiourea compounds may be connected with the serotonergic system. Derivatives 2, 10, 12, 18 acted as inhibitors of the head twitch responses (HTR).The biological activity of 21 was also linked with the endogenous opioid system. The derivative 18 diminished the spontaneous mobility and 10 reduced the amphetamineinduced activity of laboratory animals.
Export Options
About this article
Cite this article as:
Bielenica Anna, Kedzierska Ewa, Fidecka Sylwia, Maluszynska Hanna, Miroslaw Barbara, E. Koziol Anna, Stefanska Joanna, Madeddu Silvia, Giliberti Gabriele, Sanna Giuseppina and Struga Marta, Synthesis, Antimicrobial and Pharmacological Evaluation of Thioureaderivatives of 4H-1,2,4-triazole, Letters in Drug Design & Discovery 2015; 12 (4) . https://dx.doi.org/10.2174/1570180811666141001010044
DOI https://dx.doi.org/10.2174/1570180811666141001010044 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gut Microbiota Modulation for Therapeutic Management of Various Diseases:
A New Perspective Using Stem Cell Therapy
Current Molecular Pharmacology Design, Synthesis, and Structure-Activity Relationship Study of Peroxisome Proliferator-Activated Receptor (PPAR) δ-Selective Ligands
Current Medicinal Chemistry Imaging Evaluation of Post-Pancreatitis Infection
Infectious Disorders - Drug Targets Irreversible LSD1 Inhibitors: Application of Tranylcypromine and Its Derivatives in Cancer Treatment
Current Topics in Medicinal Chemistry Laboratory Techniques for Human Viral Encephalitis Diagnosis
Infectious Disorders - Drug Targets Beta-blockers in Intensive Care Medicine: Potential Benefit in Acute Brain Injury and Acute Respiratory Distress Syndrome
Recent Patents on Cardiovascular Drug Discovery Current Topics on Software Use in Medicinal Chemistry: Intellectual Property, Taxes, and Regulatory Issues
Current Topics in Medicinal Chemistry Fangchinoline Inhibited Proliferation of Neoplastic B-lymphoid Cells and Alleviated Sjögren’s Syndrome-like Responses in NOD/Ltj Mice via the Akt/mTOR Pathway
Current Molecular Pharmacology Farnesyltransferase Inhibitors: A Comprehensive Review Based on Quantitative Structural Analysis
Current Medicinal Chemistry Locked Nucleic Acid Holds Promise in the Treatment of Cancer
Current Pharmaceutical Design The Role of Chest High Resolution CT and RT-PCR in Diagnosis of Different Stages of Coronavirus (COVID-19) Pneumonia
New Emirates Medical Journal Small Molecule Inhibitors of PKCθ as Potential Antiinflammatory Therapeutics
Current Topics in Medicinal Chemistry Design and Synthesis of Hg2+ Sensing Probe Based on Spirobenzopyran Derivatives
Letters in Organic Chemistry In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens
Current Pharmaceutical Design Carnitine Metabolism and Deficit - When Supplementation is Necessary?
Current Pharmaceutical Biotechnology Triazole-linked Chalcone and Flavone Hybrid Compounds Based on AZT Exhibiting In Vitro Anti-Cancer Activity
Letters in Drug Design & Discovery Structural Genomics and Drug Discovery for Infectious Diseases
Infectious Disorders - Drug Targets Insight to Combat Post COVID-19 Mortality: Complications and their Biomarkers
Current Molecular Medicine Novel Anti-Prostate Cancer Curcumin Analogues That Enhance Androgen Receptor Degradation Activity
Anti-Cancer Agents in Medicinal Chemistry 5-HT3 Serotonin Receptor Agonists: A Pharmacophoric Journey
Current Medicinal Chemistry - Central Nervous System Agents